1. Rockman, H.A., Koch, W.J., and Lefkowitz, R.J. (2002) Seven-trans-membrane-spanning receptors and heart function. Nature. 415, 206212.

2. del Monte, F., Kaufmann, A.J., Poole-Wilson, P.A., et al. (1993) Coexistence of functioning |3-1 and |3-2 adrenoreceptors in single myocytes from human ventricle. Circulation. 88, 854-863.

3. Bristow, M.R., Hershberger, R.E., Port, J.D., et al. (1990) B-adren-ergic pathways in non-failing and failing human ventricular myocardium. Circulation. 82, 112-125.

4. Opie, L. (1998) Receptors and signal transduction, in The Heart: Physiology, From Cell to Circulation, 3rd Ed. (Opie, L., ed.), Lippincott, Williams, and Wilkins, Philadelphia, PA, pp. 173-207.

5. Hohl, C.M. and Li, Q. (1991) Compartmentation of camp in adult canine ventricular myocytes. Relation to single cell free calcium transients. Circ Res. 69, 1369-1379.

6. Lader, A.S., Xiao, Y.F., Ishikawa, Y., et al. (1998) Cardiac Gsa overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. Proc Natl Acad Sci USA. 95, 9669-9674.

7. Port, J.D. and Bristow, M.R. (2001) Altered B-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol. 33, 887-905.

8. Gauthier, C., Langin, D., and Balligand, J.L. (2000) B3-adreno-ceptors in the cardiovascular system. Trends Pharmacol Sci. 21, 426-431.

9. Laporte, S.A., Oakley, R.H., Holt, J.A., Barak, L.S., and Caron, M.G.

(2000) The interaction of p-arrestin with the AP-2 adaptor is required for the clustering of |3-2 adrenergic receptor into clathrin coated pits. J Biol Chem. 275, 23,120-126.

10. Luttrell, L.M., Ferguson, S.S., Daaka, Y., et al. (1999) B-arrestin-dependent formation of |3-2 adrenergic receptor-Src protein kinase complexes. Science. 283, 655-661.

11. Shenoy, S.K., McDonald, P.H., Kohout, T.A., and Lefkowitz, R.J.

(2001) Regulation of receptor fate by ubiquitination of activated |3-2 adrenergic receptor and p-arrestin. Science. 294, 1574-1577.

12. Mann, D., Kent, R., Parsons, B., and Cooper, I.V.G. (1992) Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85, 790-804.

13. Bristow, M.R., Ginsburg, R., Umans, V., et al. (1986) B 1 and b 2-adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective b 1-receptor down-regulation in heart failure. Circ Res. 59, 297-309.

14. Ungerer, M., Parruti, G., Bohm, M., et al. (1994) Expression of |3-arrestins and ^-adrenergic receptor kinases in the failing human heart. Circ Res. 74, 206-213.

15. Steinberg, S.F. (1999) The molecular basis for distinct |3-AR subtype action in cardiomyocytes. Circ Res. 85, 1101-1111.

16. Lader, A.S., Xiao, Y.F., Ishikawa, Y., et al. (1998) Cardiac Gsa overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. Proc Natl Acad Sci USA. 95, 9669-9674.

17. Communal, C., Singh, K., Sawyer, D.B., and Colucci, W.S. (1999) Opposing effects of |3-1 and |3-2 adrenergic receptor on cardiac myocyte apoptosis: role of a pertussis toxin sensitive G protein. Circulation. 100, 2210-2212.

18. Zaugg, M., Xu, W., Lucchinetti, E., Shafiq, S.A., Jamali, N.Z., and Siddiqui, M.A. (2000) B-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation. 102, 344-350.

19. Bisognano, J.D., Weinberger, H.D., Bohlmeyer, T.J., et al. (2000) Myocardial-directed overexpression of the human p-1-adrenergic receptor in transgenic mice. J Mol Cell Cardiol. 32, 817-830.

20. Saito, S., Hiroi, Y., Zou, Y., et al. (2000) B-adrenergic pathway induces apoptosis through calcineurin activation in cardiac myo-cytes. J Biol Chem. 275, 34,528-34,533.

21. Lowes, B.D., Gill, E.A., Abraham, W.T., et al. (1999) Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol. 83, 1201-1205.

22. Liggett, S.B., et al. (1998) The Ile164 B-2 AR polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest. 102, 1534-9.

23. Wagoner, L.E., Craft, L.L., Singh, B., et al. (2000) Polymorphisms of the |3-2 AR determine exercise capacity in patients with heart failure. Circ Res. 86, 834-840.

24. Graham, R.M., Perez, D.M., Hwa, J., and Piascik, M.T. (1996) AlphaAR subtypes. Molecular structure, function and signaling. Circ Res. 78, 737-749.

25. Otani, H., Otani, H., and Das, D.K. (1988) Alpha-1 adrenoreceptor mediated phosphoinisotidie breakdown and inotropic response in rate left ventricular papillary muscles. Circ Res. 62, 8-17.

26. Hwang, K.C., Grady, C.D., Sweet, W.E., and Moravec, C.S. (1996) Alpha-1 adrenergic receptor coupling with Gh in the failing human heart. Circulation. 94, 718-726.

27. Choi, D.J.,Koch, W.J., Hunter, J.J., and Rockman, H.A. (1997) Mechanism of p-adrenergic receptor desensitization in cardiac hypertrophy is increased p-ARK. J Biol Chem. 272, 17,223-17,229.

28. Knowlton, K.U., Michel, M.C., Itani, M., et al. (1993) The a1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem. 268, 15,374-15,380.

29. Sugden, P.H. (1999) Signaling in myocardial hypertrophy: life after calcineurin? Circ Res. 84, 633-646.

30. Barki-Harrington, L., Luttrell, L.M., and Rockman, H.A. (2003) Dual inhibition of p-adrenergic and angiotensin II receptors by a single antagonist. Circulation. 108, 1611-1618.

31. Dzimiri, N. (2002) Receptor crosstalk: Implications for cardiovascular function, disease and therapy. Eur J Biochem. 269, 4713-4730.

32. Munzel, T., Feil, R., Mulsch, A., Lohmann, S.M., Hofmann, F., and Walter, U. (2003) Physiology and pathophysiology of vascular signaling controlled by cyclic guanosine 3',5'-cyclic monophosphate-dependent protein kinase. Circulation. 108, 2172-2183.

33. von der Leyen, H.E. and Dzau, V.J. (2001) Therapeutic potential of nitric oxide synthase gene manipulation. Circulation. 103, 27602765.

34. Loscalzo, J. (2001) Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res. 88, 756-7562.

35. Champion, H.C., Skaf, M.W., and Hare, J.M. (2003) Role of nitric oxide in the pathophysiology of heart failure. Heart Fail Rev. 8, 35-46.

36. Jugdutt, B.I. (2003) Nitric oxide and cardiovascular protection. Heart Fail Rev. 8, 29-34.

37. Young-Myeong, K., Bombeck, C.A., and Billiar, T.R. (1999) Nitric oxide as a bifunctional regulator of apoptosis. Circ Res. 84, 253-256.

38. Kuhn, M. (2003) Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase A. Circ Res. 93, 700-709.

Was this article helpful?

0 0
Essentials of Human Physiology

Essentials of Human Physiology

This ebook provides an introductory explanation of the workings of the human body, with an effort to draw connections between the body systems and explain their interdependencies. A framework for the book is homeostasis and how the body maintains balance within each system. This is intended as a first introduction to physiology for a college-level course.

Get My Free Ebook

Post a comment